Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Interactions with E/C/F/TAF (Genvoya)

Tuesday 01 December 2015

The web and app versions of the interaction charts have been updated to include Genvoya®, a single tablet regimen containing elvitegravir, cobicistat, emtricitabine (FTC) and tenofovir alafenamide. Interactions are listed under the abbreviation E/C/F/TAF and the combination is currently classified as an integrase inhibitor.
 
We are preparing updated records for elvitegravir/cobicistat to reflect fully its administration as a single tablet regimen with emtricitabine and tenofovir-DF (Stribild®). Once this has been completed, the printable charts will be updated with these changes.
SPONSORS
Sponsor logo janssen Sponsor logo gilead Sponsor logo msd Sponsor logo viiv
EDITORIAL SPONSORS
Hiv  glasgow 2018 cmyk logo Eacs logo 2014 Bhiva 2018 Basel text
Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017 rcp-excellence-patient-care-awards-2017 building_better_healthcare_awards_2016